» Articles » PMID: 36833170

Linear Diagnostic Procedure Elicited by Clinical Genetics and Validated by MRNA Analysis in Neuronal Ceroid Lipofuscinosis 7 Associated with a Novel Non-Canonical Splice Site Variant in

Abstract

Neuronal ceroid lipofuscinoses (CNL) are lysosomal storage diseases that represent the most common cause of dementia in children. To date, 13 autosomal recessive (AR) and 1 autosomal dominant (AD) gene have been characterized. Biallelic variants in cause CLN7 type, with nearly 50 pathogenic variants, mainly truncating and missense, reported so far. Splice site variants require functional validation. We detected a novel homozygous non-canonical splice-site variant in in a 5-year-old girl who presented with progressive neurocognitive impairment and microcephaly. The diagnostic procedure was elicited by clinical genetics first, and then confirmed by cDNA sequencing and brain imaging. Inferred by the common geographic origin of the parents, an autosomal recessive inheritance was hypothesized, and SNP-array was performed as the first-line genetic test. Only three AR genes lying within the observed 24 Mb regions of homozygosity were consistent with the clinical phenotype, including , and . The cerebral and cerebellar atrophy detected in the meantime by MRI, along with the suspicion of accumulation of ceroid lipopigment in neurons, prompted us to perform targeted sequencing. Following the detection of a splice site variant of uncertain significance, skipping of exon 8 was demonstrated by cDNA sequencing, and the variant was redefined as pathogenic.

Citing Articles

Neuronal ceroid lipofuscinoses type 7 (CLN7): a case series reporting cross sectional and retrospective clinical data to evaluate validity of standardized tools to assess disease progression, quality of life, and adaptive skills.

Kayani S, BordesEdgar V, Lowden A, Nettesheim E, Dahshi H, Messahel S Orphanet J Rare Dis. 2024; 19(1):468.

PMID: 39702211 PMC: 11657365. DOI: 10.1186/s13023-024-03448-8.


Neuronal Ceroid Lipofuscinoses Type 7 (CLN7)- A Case Series Reporting Cross Sectional and Retrospective Clinical Data to Evaluate Validity of Standardized Tools to Assess Disease Progression, Quality of Life, and Adaptive Skills.

Kayani S, Bordes Edgar V, Lowden A, Nettesheim E, Dahshi H, Messahel S Res Sq. 2024; .

PMID: 38978590 PMC: 11230482. DOI: 10.21203/rs.3.rs-3983366/v1.


Recognizing Lipofuscinosis as a Guide in Antiepileptic Treatment: Clinical Description of the First Mexican Case With Neuronal Ceroid Lipofuscinosis Type 7 (NCL7).

Kimball T, Garcia-Rueda A, Rivero-Garcia P, Perez-Segovia A, Mayoral-Carrasco L Cureus. 2024; 16(3):e56914.

PMID: 38659533 PMC: 11042739. DOI: 10.7759/cureus.56914.

References
1.
Mole S, Williams R, Goebel H . Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 2005; 6(3):107-26. DOI: 10.1007/s10048-005-0218-3. View

2.
Patino L, Battu R, Ortega-Recalde O, Nallathambi J, Anandula V, Renukaradhya U . Exome sequencing is an efficient tool for variant late-infantile neuronal ceroid lipofuscinosis molecular diagnosis. PLoS One. 2014; 9(10):e109576. PMC: 4198115. DOI: 10.1371/journal.pone.0109576. View

3.
Steenhuis P, Froemming J, Reinheckel T, Storch S . Proteolytic cleavage of the disease-related lysosomal membrane glycoprotein CLN7. Biochim Biophys Acta. 2012; 1822(10):1617-28. DOI: 10.1016/j.bbadis.2012.05.015. View

4.
Reith M, Zeltner L, Schaferhoff K, Witt D, Zuleger T, Haack T . A Novel, Apparently Silent Variant in Causes Neuronal Ceroid Lipofuscinosis with Marked Intrafamilial Variability. Int J Mol Sci. 2022; 23(4). PMC: 8877174. DOI: 10.3390/ijms23042271. View

5.
Aldahmesh M, Al-Hassnan Z, Aldosari M, Alkuraya F . Neuronal ceroid lipofuscinosis caused by MFSD8 mutations: a common theme emerging. Neurogenetics. 2009; 10(4):307-11. DOI: 10.1007/s10048-009-0185-1. View